CLINIQUE TARGETED PROTECTION SPF 45 BROAD SPECTRUM SUNSCREEN- homosalate, octisalate, and avobenzone stick 
CLINIQUE LABORATORIES LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

CLINIQUE TARGETED PROTECTION STICK SPF 45 BROAD SPECTRUM SUNSCREEN

Drug Facts

Active ingredients

Avobenzone 3.0%
Homosalate 5.0%
Octisalate 5.0%

Purpose

Sunscreen

Use

helps prevent sunburn

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

Inactive ingredients

microcrystalline wax\cera microcristallina\cire microcristalline • jojoba esters • phenyl trimethicone • simmondsia chinensis (jojoba) butter • cetyl ricinoleate • butyloctyl salicylate • polyester-8 • beeswax\cera alba\cire d'abeille • polyethylene • tocopheryl acetate • vp/eicosene copolymer • tocopherol [iln35001]

Other information

protect the product in this container from excessive heat and direct sun

PRINCIPAL DISPLAY PANEL - 6 g Cylinder Carton

CLINIQUE

broad
spectrum
SPF 45
sunscreen

UVA | UVB
PROTECTION

targeted
protection
stick

NET WT. .21 OZ.
6g e

Principal Display Panel  - 6 g Cylinder Carton
CLINIQUE TARGETED PROTECTION SPF 45 BROAD SPECTRUM SUNSCREEN 
homosalate, octisalate, and avobenzone stick
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-041
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE5 g  in 100 g
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 g
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)  
PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
JOJOBA BUTTER (UNII: XIA46H803R)  
CETYL RICINOLEATE (UNII: 1P677500YD)  
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
TOCOPHEROL (UNII: R0ZB2556P8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-041-011 in 1 CARTON12/01/2008
16 g in 1 CYLINDER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM02012/01/2008
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder Cosmetics Ltd.202952982manufacture(49527-041)
Establishment
NameAddressID/FEIBusiness Operations
Estee Lauder Cosmetics Ltd.204132062pack(49527-041) , label(49527-041)

Revised: 7/2023
Document Id: 0190664c-6a4c-e654-e063-6394a90a2cbf
Set id: f4fe22b3-ccf2-4d67-8d20-5b5d3b69b444
Version: 8
Effective Time: 20230728
 
CLINIQUE LABORATORIES LLC